Aqr Capital Management LLC Outlook Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.91 - $2.01 $4,841 - $10,693	-5,320 Reduced 9.27%	52,041 $53,000
Q1 2022 May 16, 2022	SELL	$1.22 - $2.03 $15,849 - $26,371	-12,991 Reduced 18.47%	57,361 $102,000
Q4 2021 Feb 14, 2022	BUY	$1.27 - $2.23 $1,676 - $2,943	1,320 Added 1.91%	70,352 $96,000
Q3 2021 Nov 15, 2021	BUY	$2.12 - $2.76 $70,038 - $91,182	33,037 Added 91.78%	69,032 $150,000
Q2 2021 Aug 16, 2021	BUY	$1.78 - $2.76 $64,071 - $99,346	35,995 New	35,995 $90,000

31.5K

Ticker OTLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,144,992
Market Cap $520M
Description
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.